Search

everythinglearnresearchcommunity

for

Search:↓

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Lack of certain nutrients may contribute to hair loss and proper diet or supplements could improve it.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

COVID-19 vaccination may trigger lupus in some people.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

AGA linked to worse COVID-19 outcomes in men.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

Men with severe balding have a higher risk of getting very sick from COVID-19.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.